Discover the Vimachem Pharma MES Platform
Italy Pharma Track & Trace: What's Coming in 2027 and How Vimachem Can Help You Comply
Italy Pharma Track & Trace: What's Coming in 2027 and How Vimachem Can Help You Comply
Saud Khan
Senior IT Serialization Consultant
Italy is in the closing stretch of one of the more unusual serialization transitions in Europe. Unlike a market adopting Track & Trace for the first time, Italy already had one, the Bollino label scheme, running for years under an EU exemption. That exemption ends on 8 February 2027. From the following day, only the harmonized EU Falsified Medicines Directive model is accepted, and the national verification system already went live on the EU Hub in May 2026. For MAHs, CMOs, parallel distributors, and wholesalers supplying the Italian market, the message is the same one heard in every serialization rollout: get ready before the deadline closes the door on the old way of doing things.
A walk through the Serialization Site Manager
Regulatory Timeline at a Glance
The legal foundation is Italian Legislative Decree 10/2025, approved by the Council of Ministers on 28 January 2025, which sets a two-year stabilization period aligning Italy with Commission Delegated Regulation (EU) 2016/161. The stabilization period runs from 9 February 2025 to 8 February 2027. During this window, the Bollino and EU-style serialization, a 2D Data Matrix unique identifier plus an anti-tampering device, can be used side by side, and penalties for missing the Data Matrix or anti-tampering feature are not enforced. After 8 February 2027, the Bollino is no longer valid. Every pack placed on the Italian market must carry the unique identifier and anti-tampering device required under the EU model.
The most recent milestone landed on 11 May 2026: Italy’s National Medicines Verification System connected to the EU Hub production environment. MAHs and On-Boarding Partners are now expected to load product master data with NMVO Italia and finalize packaging artwork, including the GS1 Data Matrix and the “Allegato B” safety device. Batch release during this phase runs through a dedicated pilot, Pilota Fase 2, with enrollment coordinated by pharma industry associations and guidance issued through the Tavolo Tecnico di Monitoraggio established under the Ministerial Decree of 4 March 2025.
What This Means for Italy
Italy’s approach is not a greenfield build the way some emerging markets are. It is a controlled retirement of a system that already worked, replaced by the model the rest of the EU already runs on. That makes it look simpler on paper, but it carries its own complexity: companies have to run two systems in parallel through the stabilization period, keep Bollino-labeled stock moving while onboarding to NMVO Italia, and get packaging artwork, master data, and reporting connections ready before the parallel option disappears.
At pack level, the destination state is the same GS1 Data Matrix and anti-tampering device used across the rest of the EU, carrying the GTIN, unique serial number, batch, and expiry. What is specific to Italy is the transition path getting there: NMVO Italia registration, a nationally coordinated pilot phase, and a fixed cutover date rather than a phased market-by-market rollout.
Who Should Act Now?
As with every serialization transition, the scope extends beyond manufacturers:
- MAHs (AIC holders) supplying the Italian market.
- CMOs packaging for Italy, whether based in Italy or exporting into it.
- Parallel distributors and wholesalers moving product through the Italian supply chain.
- On-Boarding Partners coordinating NMVO Italia registration on behalf of MAHs.
- Pharmacies and dispensing points as the downstream endpoint of the verification chain.
The practical reality is simple: if any link in the chain is still running on Bollino-only processes after 8 February 2027, that stock cannot legally move.
Why Preparation Matters & Why to Prepare Early
Italy’s stabilization period was never framed as a grace period by the authorities involved, and the update in May 2026 confirmed why. It is the working window, and with roughly 21 months left on the clock as of that update, five readiness fronts need attention in parallel: packaging and artwork, serialization and master data management, system and process integration with NMVO Italia, partner onboarding, and authority reporting. Leaving any one of these until the months before the deadline risks packaging rework, incomplete serialization data, and stock that cannot clear verification once the Bollino option is gone.
Why You Should Choose Vimachem as Your Compliance Partner
At Vimachem, our key differentiator is not just compliance but flexibility, scalability, and operational excellence. Vimachem combines regulatory expertise with a flexible and practical approach to pharmaceutical serialization. Our modular platform can be adapted to different site architectures, packaging lines, business processes, and market requirements without forcing customers into a fixed vendor ecosystem. Whether a company needs a Level 3 site system, combined Level 3/4 capabilities, warehouse traceability, or manual serialization and aggregation, the solution can be configured around the actual operational scope and expanded as requirements evolve.
This flexibility also enables faster implementation and lower disruption during regulatory transitions such as Italy’s move from Bollino to the EU FMD model. Vimachem supports phased rollouts, integration with different Level 2 and enterprise systems, and controlled validation while production continues. Customers gain a scalable compliance platform that can respond quickly to new markets, additional lines, and changing regulations without unnecessary complexity or long-term vendor lock-in.
Direct Connectivity to NMVO Italia and the EU Hub
Italy’s transition depends on a working connection to NMVO Italia and, through it, the EU Hub. Vimachem’s Level 3/4 Serialization Site Manager connects directly to this infrastructure, managing product master data submission, unique identifier commissioning, and event reporting so that batches released under Pilota Fase 2 or under full EU serialization after the cutover are handled the same way, without a separate system for each phase.
Modular, Flexible, and Line-Agnostic
Vimachem’s platform is modular by design, enabling companies to deploy only what they need, when they need it. The Vimachem Serialization Site Manager Level 3/4 solution is L2-agnostic, giving our customers the flexibility to select the most appropriate Level 2 solution for each packaging line, from high-speed automated lines to low-speed or semi-automatic lines or even fully manual serialization and aggregation scenarios. This flexibility avoids overengineering and significantly reduces long-term cost and vendor lock-in. With 50+ customers globally using various L2s across the site, we have proven that flexibility and avoidance of vendor lock-in are the most secure and cost-efficient way to initiate and scale your pharmaceutical serialization operations.
Built for Zero Downtime Operations
Serialization should never compromise supply continuity, and Italy’s stabilization period makes that especially true: production has to keep running while artwork changes from Bollino to the EU Data Matrix and anti-tampering device. Vimachem’s solutions are designed to go live with no production downtime, supporting parallel rollout, phased go-lives, and controlled validation strategies. This allows companies to remain fully operational while transitioning their labeling and reporting capabilities ahead of the 8 February 2027 cutover.
The Vimachem Serialization Modules
We provide pharmaceutical companies with modular and regulatory-ready serialization solutions that support pharmaceutical companies across packaging, warehousing, and distribution.
Our portfolio is designed to scale with evolving global requirements, including transitions such as Italy’s:
Vimachem Level 3 / Level 4 Serialization Site Manager (SSM)
Italy’s NMVO Italia onboarding and EU Hub connectivity make Level 3 the center of gravity for compliance. Vimachem’s Level 3/4 SSM sits between packaging lines (Level 2) and NMVO Italia, reducing compliance risk and go-live pressure while giving companies control and auditability through the transition. With Vimachem Level 3/4 SSM, companies can:
- Manage the shift from Bollino to EU-model artwork through the Layout Manager, publishing and reverting label layouts without stopping the line.
- Submit and reconcile product master data and unique identifiers with NMVO Italia, keeping packaging orders aligned with what the national system expects.
- Support compliance reporting workflows for both the stabilization period and full EU serialization, so the data leaving your site stays consistent, complete, and inspection-ready across the cutover.
// SSM
See the Product Tour
Vimachem Smart Warehouse Traceability (SWT)
Italy’s transition doesn’t stop at the packaging line. Once product moves through distribution under the EU model, warehouses and 3PLs need to handle aggregated, verification-ready stock with confidence. Vimachem’s Smart Warehouse Traceability (SWT) supports scan-driven receiving and shipping that protects the pack-to-case-to-pallet relationship throughout logistics, keeping distributor and wholesaler operations aligned with what NMVO Italia and the EU verification system expect.
// SWT
See the Product Tour
Looking Ahead to 2027
Italy’s serialization transition closes on 8 February 2027, with the working window already active since the EU Hub connection went live in May 2026. Companies that treat the remaining months as an operational program, not a last-minute artwork update, will move through the cutover without disrupting supply. With Vimachem’s serialization solutions, pharmaceutical companies can manage the shift from Bollino to full EU compliance while strengthening supply chain visibility and control across the transition and beyond.
Discover how the Vimachem Pharma MES Platform helps you avoid compliance gaps as Italy's serialization requirements come into force
// Want to learn more?
